FY2025 EPS Estimate for Merck & Co., Inc. Reduced by Analyst
Merck & Co., Inc. (NYSE:MRK – Free Report) – Equities research analysts at Cantor Fitzgerald cut their FY2025 earnings per share estimates for shares of Merck & Co., Inc. in a research report issued to clients and investors on Wednesday, April 30th. Cantor Fitzgerald analyst C. Gould now anticipates that the company will post earnings […]
